PMID: 16870082

Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.

Buzdar Aman, Chlebowski Rowan, Cuzick Jack, Duffy Sean, Forbes John, Jonat Walter, Ravdin Peter

Current medical research and opinion · 2007

Vol. 22, Issue 8, pp. 1575-85

View on PubMedDOI

This entry links to third-party literature. For research use only.

Antineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsAromatase InhibitorsBreast NeoplasmsCarcinoma, Ductal, BreastChemotherapy, AdjuvantClinical Trials as TopicConsensusDisease-Free SurvivalFemale

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.